BRAF mutation status does not impact outcomes with tebentafusp in advanced cutaneous melanoma Meeting Abstract


Authors: Shoushtari, A. N.; Middleton, M. R.; Hamid, O.; Meier, F.; Bauer, T.; Salama, A. K. S.; Kirkwood, J. M.; Ascierto, P. A.; Lorigan, P.; Mauch, C.; Orloff, M.; Edukulla, R.; Goodall, H.; Hassel, J. C.; Evans, T. R. J.
Abstract Title: BRAF mutation status does not impact outcomes with tebentafusp in advanced cutaneous melanoma
Meeting Title: ESMO Congress 2023
Journal Title: Annals of Oncology
Volume: 34
Issue: Suppl. 2
Meeting Dates: 2023 Oct 20-24
Meeting Location: Madrid, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2023-10-01
Start Page: S667
End Page: S668
Language: English
ACCESSION: WOS:001087480201436
DOI: 10.1016/j.annonc.2023.09.2241
PROVIDER: wos
Notes: Meeting Abstract: 1107P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors